Lifecore Biomedical Inc
F:LDE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lifecore Biomedical Inc
F:LDE
|
US |
Intrinsic Value
The intrinsic value of 
Lifecore Biomedical Inc (LDE) under the Base Case is 10.09 EUR per share.
Compared with the current market price of 5.55 EUR, the stock appears
Undervalued by 45% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Lifecore Biomedical Does
Lifecore Biomedical makes and packages sterile injectable medicines for other drug companies. It also manufactures hyaluronic acid, a key ingredient used in some eye, joint, and surgical products. The company sits in the middle of the pharmaceutical supply chain, helping customers turn drug formulas into finished, sterile products that can be sold to hospitals, clinics, and patients.
- Headquarters
- United States of America US
- Employees
- 400
- IPO date
- Feb 15, 1996
Revenue & Expenses Breakdown
Lifecore Biomedical Inc
Earnings Waterfall
Lifecore Biomedical Inc
The intrinsic value for Lifecore Biomedical Inc (LDE) under the Base Case is 10.09 EUR.
Compared with the current market price of 5.55 EUR, the stock appears Undervalued by 45% .
